Educational courses during the 13th WG Annual meeting
Educational session 1: Diagnosis of cardiomyopathies
Chairs: A.L. Caforio, S.B. Felix
Introduction
Definition and classification -an overview - Y. Pinto
Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - Prof. H. Katus
Contra - H.-P. Schultheiss
Advances in imaging: echocardiography, MRI, CT and PET – what is essential for diagnostic work-up? - A. Linhart
The MOGE(S) Classification for a phenotype- genotype nomenclature of cardiomyopathy - E. Arbustini
Prognostic Relevance of gene-environment interactions in patients with dilated cardiomyopathy - S. Heymans
Educational session 2: Personalized medicine for diagnosis and treatment of myocarditis and inflammatory cardiomyopathy
Chairs: A. Anastasakis, R. Jahns
Diagnostic work up in myocarditis and DCM - M. Dörr
Endomyocardial biopsy is essential for diagnosis - C. Basso
Role of cardiovascular magnetic resonance - J. Schulz-Menger
From evidence-based treatment to future direction for research in inflammatory cardiomyopathy - U. Eriksson
Educational session 3: Hypertrophic cardiomyopathy: From bench to bedside
Chairs: P. Elliott, A. Rigopoulos
Stepwise approach for risk stratification - P. Elliott
Next generation genetic testing – What next - J. Mogensen
Gene therapy for inherited sarcomeric pediatric cardiomyopathy - L. Carrier
Evidence-based medical treatment - J. Olivotto
Evidence-based percutaneous gradient ablation - H. Seggewiss
Surgical therapies - P. Ferrazzi
Educational session 4: Myocardial involvement in systemic immune-mediated diseases: Focus on the myocardial and pericardial disease Position paper
Chairs: E. Arbustini, A. L. Caforio
Systemic autoimmune diseases and cardiac involvement: Focus on animal models and common mechanisms -V. Poli
What’s new: The cardiac pathologist’s point of view -K. Klingel
What’s new: The cardiologist’s point of view -S.B. Felix
What’s new: The immunologist’s point of view -R. Marcolongo
What next -U. Eriksson
Extra-educational session 4: The Noncoding genome in myocardial diseases – Pathogenic implications and therapeutic perspectives for the cardiomyopathies
Chairs: M. Arad, P. Charron
Noncoding RNAs in cardiovascular disease – Status of clinical translation - T. Thum
MicroRNAs in cardiac fibrosis and hypertrophy - S. Engelhardt
Monocyte-directed RNAi in cardiac inflammation - F. Leuschner
Gene editing - J.-S. Hulot
Methylome - B. Meder
Gene and microRNA based therapies for heart failure Status of clinical translation - R. Hajjar
Extra educational session 5: Diastolic and systolic dysfunction in heart failure and the cardiomyopathies – From diagnosis to treatment
Chairs: M. Fu, A. Ristic
Immunoadsorption as a treatment option in DCM - S. B. Felix
Current evidence on treatment of patients with chronic systolic heart failure - A. Ristic
Cardiac implantable electronic devices in systolic heart failure - M. Busch
Systolic heart failure: New drugs in the pipeline - B. Pieske
New treatment options for diastolic dysfunction - G. Hasenfuß
Keynote Lecture - Myocardial regeneration in the cardio- myopathies – A therapeutic option? Basic research - T. Eschenhagen
Clinical trials - S. Janssens
Educational session 5: Rare myocardial diseases – From diagnosis to treatment
Chairs: A. L. Caforio, M. Dörr
Pediatric diseases - G. Limongelli
Anderson-Fabry disease - A. Linhart
Glycogen storage disease - M. Arad
Amyloidosis - C. Rapezzi
Neuro-muscular disease - A. Pantazis
Inflammatory cardiomyopathies - C. Basso
Keynote Lecture: Rare cardiomyopathies-challenges and opportunities - P. Elliott
Educational session 6: Diagnosis and treatment of pericardial diseases – Focus on the 2015 Guidelines
Chairs: S. Pankuweit, A. Ristic
Clinical and diagnostic work-up - B. Maisch
Medical treatment - M. Imazio
What next - Y. Adler
Educational session 7: Acute decompensated chronic heart failure – A diagnostic and therapeutic challenge in cardiomyopathies of different aetiologies
Chairs: S. Blankenberg, A. Keren
The diagnostic accuracy of the natriuretic peptides in heart failure - J. Mant
New drugs for treatment of acute decompensated heart failure – Mitrovic
Ultrafiltration in patients with acute decompensated chronic heart failure - G. Marenzi
Impella ventricular support in patients with cardiogenic shock - M. Ferrari
Emergency extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock – D. Westermann
Keynote Lecture: Auto-immune mechanisms in myocarditis and dilated cardiomyopathy - A. L. Caforio
Educational session 8: Arrhythmogenic cardiomyopathies
Chairs: A. Anastasakis, P. Elliott
Pathology – Still the gold standard? C. Basso
Genetic diagnosis – An update for the clinician - E. Arbustini
Clinical and non-invasive work-up - A. Tsatsopoulou
Risk stratification - T. Wichter
Keynote Lecture: Treatment of ARVC: Key messages from the international and future perspectives - D. Corrado
Our mission: To reduce the burden of cardiovascular disease.